Skip to main content
NCBI home page
Annals of Surgery logoLink to Annals of Surgery
. 1978 Dec;188(6):783–790. doi: 10.1097/00000658-197812000-00012

Jaundice after Renal Allotransplantation

Martin F Mozes, Nancy L Ascher, Henry H Balfour Jr, Richard L Simmons, John S Najarian
PMCID: PMC1397014  PMID: 216323

Abstract

Of 567 patients receiving renal transplantation at the University of Minnesota between October 1967 and October 1975, 22 developed clinical jaundice. Of these 22, nine died with their initial episode of hepatitis, six died within three months of causes associated with liver malfunction, four developed evidence of chronic hepatic failure and only three totally recovered from their illness. Five had clear evidence of Australia antigen positive hepatitis B, four of cytomegalovirus hepatitis, two of herpes hominis hepatitis, one of varicella zoster hepatitis and three of hepatic failure associated with systemic bacterial and/or fungal sepsis. Two of the 22 patients were thought likely to have cytomegalovirus hepatitis though definite proof was absent and in five patients a clear-cut etiology could not be made. In many of these patients the diagnosis was confounded by the previous presence of HBsAg antigen and the frequent occurrence of a previous or concurrent infection with cytomegalovirus. The role of various drugs including azathioprine, sulfisoxazole, chlorpromazine, acetominophen, etc., could not be established but major roles for these agents in the face of the many viral and bacterial infections present in these patients is doubted. No clear-cut therapy could be established although it appears safe to discontinue azathioprine for longer or shorter periods of time with or without substitution of cyclophosphamide without serious deterioration of renal function. The problem of hepatic failure in transplant patients is still unsolved and will require a prospective study of etiologic agents and sub-clinical hepatic dysfunction in order to establish even the first principles of clinical-pathological correlation.

Full text

PDF
783

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aldrete J. S., Sterling W. A., Hathaway B. M., Morgan J. M., Diethelm A. G. Gastrointestinal and hepatic complications affecting patients with renal allografts. Am J Surg. 1975 Feb;129(2):115–124. doi: 10.1016/0002-9610(75)90286-x. [DOI] [PubMed] [Google Scholar]
  2. Andersen H. K., Spencer E. S. Cytomegalovirus infection among renal allograft recipients. Acta Med Scand. 1969 Jul-Aug;186(1-2):7–19. doi: 10.1111/j.0954-6820.1969.tb01432.x. [DOI] [PubMed] [Google Scholar]
  3. Aronoff A., Gault M. H., Huang S. N., Lal S., Wu K. T., Moinuddin M. D., Spence L., MacLean L. D. Hepatitis with Australia antigenemia following renal transplantation. Can Med Assoc J. 1973 Jan 6;108(1):43–50. [PMC free article] [PubMed] [Google Scholar]
  4. Bach J. F., Dardenne M. Serum immunosuppressive activity of azathioprine in normal subjects and patients with liver diseases. Proc R Soc Med. 1972 Mar;65(3):260–263. doi: 10.1177/003591577206500316. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Balfour H. H., Jr, Groth K. E., McCullough J., Kalis J. M., Marker S. C., Nesbit M. E., Simmons R. L., Najarian J. S. Prevention or modification of varicella using zoster immune plasma. Am J Dis Child. 1977 Jun;131(6):693–696. doi: 10.1001/archpedi.1977.02120190087020. [DOI] [PubMed] [Google Scholar]
  6. Berne T. V., Chatterjee S. N., Craig J. R., Payne J. E. Hepatic dysfunction in recipients of renal allografts. Surg Gynecol Obstet. 1975 Aug;141(2):171–175. [PubMed] [Google Scholar]
  7. Briggs W. A., Lazarus J. M., Birtch A. G., Hampers C. L., Hager E. B., Merrill J. P. Hepatitis affecting hemodialysis and transplant patients. Its considerations and consequences. Arch Intern Med. 1973 Jul;132(1):21–28. [PubMed] [Google Scholar]
  8. Chatterjee S. N., Payne J. E., Redeker A. G., Berne T. V. Successful renal transplantation in patients positive for hepatitis B antigen. N Engl J Med. 1974 Jun 11;291(2):62–65. doi: 10.1056/NEJM197407112910202. [DOI] [PubMed] [Google Scholar]
  9. Conrad M. E., Knodell R. G. Viral hepatitis--1975. JAMA. 1975 Sep 22;233(12):1277–1278. doi: 10.1001/jama.233.12.1277. [DOI] [PubMed] [Google Scholar]
  10. Craighead J. E., Hanshaw J. B., Carpenter C. B. Cytomegalovirus infection after renal allotransplantation. JAMA. 1967 Sep 4;201(10):725–728. [PubMed] [Google Scholar]
  11. Eddleston A. L., Williams R. Inadequate antibody response to hBAg or suppressor T-cell defect in development of active chronic hepatitis. Lancet. 1974 Dec 28;2(7896):1543–1545. doi: 10.1016/s0140-6736(74)90287-6. [DOI] [PubMed] [Google Scholar]
  12. FAHRLAENDER H., HUBER F., GLOOR F. INTRAHEPATIC RETENTION OF BILE IN SEVERE BACTERIAL INFECTIONS. Gastroenterology. 1964 Dec;47:590–599. [PubMed] [Google Scholar]
  13. Freiberger Z., Anuras S., Koff R. S., Bonney W. W. Chronic active hepatitis without hepatitis B antigenemia in renal transplant recipients. Report of three cases. Gastroenterology. 1974 Jun;66(6):1187–1194. [PubMed] [Google Scholar]
  14. HILL R. B., Jr, ROWLANDS D. T., Jr, RIFKIND D. INFECTIOUS PULMONARY DISEASE IN PATIENTS RECEIVING IMMUNOSUPPRESSIVE THERAPY FOR ORGAN TRANSPLANTATION. N Engl J Med. 1964 Nov 12;271:1021–1027. doi: 10.1056/NEJM196411122712001. [DOI] [PubMed] [Google Scholar]
  15. Hathaway W. E., Mull M. M., Pechet G. S. Disseminated intravascular coagulation in the newborn. Pediatrics. 1969 Feb;43(2):233–240. [PubMed] [Google Scholar]
  16. Hume D. M., Lee H. M., Williams G. M., White H. J., Ferré J., Wolf J. S., Prout G. R., Jr, Slapak M., O'Brien J., Kilpatrick S. J. Comparative results of cadaver and related donor renal homografts in man, and immunologic implications of the outcome of second and paired transplants. Ann Surg. 1966 Sep;164(3):352–397. doi: 10.1097/00000658-196609000-00003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Ireland P., Rashid A., von Lichtenberg F., Cavallo T., Merrill J. P. Liver disease in kidney transplant patients receiving azathioprine. Arch Intern Med. 1973 Jul;132(1):29–37. [PubMed] [Google Scholar]
  18. Javitt N. B. Editorial: Chronic active hepatitis. Am J Med. 1973 Dec;55(6):733–735. doi: 10.1016/0002-9343(73)90253-2. [DOI] [PubMed] [Google Scholar]
  19. Klemola E., Stenström R., von Essen R. Pneumonia as a clinical manifestation of cytomegalovirus infection in previously healthy adults. Scand J Infect Dis. 1972;4(1):7–10. doi: 10.3109/inf.1972.4.issue-1.02. [DOI] [PubMed] [Google Scholar]
  20. Lee J. C., Fortuny I. E. Adult herpes simplex hepatitis. Hum Pathol. 1972 Jun;3(2):277–281. doi: 10.1016/s0046-8177(72)80081-9. [DOI] [PubMed] [Google Scholar]
  21. Leinikki P., Heinonen K., Pettay O. Incidence of cytomegalovirus infections in early childhood. Scand J Infect Dis. 1972;4(1):1–5. doi: 10.3109/inf.1972.4.issue-1.01. [DOI] [PubMed] [Google Scholar]
  22. Levine R. A., Ranek L. Asymptomatic chronic hepatitis. Correlation between isolated serum transaminase abnormality and liver biopsy. Gastroenterology. 1970 Mar;58(3):371–378. [PubMed] [Google Scholar]
  23. Luby J. P., Burnett W., Hull A. R., Ware A. J., Shorey J. W., Peters P. C. Relationship between cytomegalovirus and hepatic function abnormalities in the period after renal transplant. J Infect Dis. 1974 May;129(5):511–518. doi: 10.1093/infdis/129.5.511. [DOI] [PubMed] [Google Scholar]
  24. Miller D. R., Hanshaw J. B., O'Leary D. S., Hnilicka J. V. Fatal disseminated herpes simplex virus infection and hemorrhage in the neonate. Coagulation studies in a case and a review. J Pediatr. 1970 Mar;76(3):409–415. doi: 10.1016/s0022-3476(70)80481-4. [DOI] [PubMed] [Google Scholar]
  25. Montgomerie J. Z., Becroft D. M., Croxson M. C., Doak P. B., North J. D. Herpes-simplex-virus infection after renal transplantation. Lancet. 1969 Oct 25;2(7626):867–871. doi: 10.1016/s0140-6736(69)92327-7. [DOI] [PubMed] [Google Scholar]
  26. Moore T. C., Hume D. M. The period and nature of hazard in clinical renal transplantation. I. The hazard to patient survival. Ann Surg. 1969 Jul;170(1):1–11. doi: 10.1097/00000658-196907000-00001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Nielsen J. O., Dietrichson O., Elling P., Christoffersen P. Incidence and meaning of persistence of Australia antigen in patients with acute viral hepatitis: development of chronic hepatitis. N Engl J Med. 1971 Nov 18;285(21):1157–1160. doi: 10.1056/NEJM197111182852101. [DOI] [PubMed] [Google Scholar]
  28. Nielsen V., Clausen E., Ranek L. Liver impairment during chronic hemodialysis and after renal transplantation. Acta Med Scand. 1975 Mar;197(3):229–234. doi: 10.1111/j.0954-6820.1975.tb04907.x. [DOI] [PubMed] [Google Scholar]
  29. Pirson Y., Alexandre G. P., Ypersele C. Long-term effect of hbs antigenemia on patient survival after renal transplantation. N Engl J Med. 1977 Jan 27;296(4):194–196. doi: 10.1056/NEJM197701272960404. [DOI] [PubMed] [Google Scholar]
  30. Pirson Y., van Ypersele de Strihou C., Noel H., Alexandre G. P., Troch R. Liver disease in transplanted patients. Proc Eur Dial Transplant Assoc. 1973;10(0):434–445. [PubMed] [Google Scholar]
  31. STARZL T. E., MARCHIORO T. L., PORTER K. A., TAYLOR P. D., FARIS T. D., HERRMANN T. J., HLAD C. J., WADDELL W. R. FACTORS DETERMINING SHORT- AND LONG-TERM SURVIVAL AFTER ORTHOTOPIC LIVER HOMOTRANSPLANTATION IN THE DOG. Surgery. 1965 Jul;58:131–155. [PMC free article] [PubMed] [Google Scholar]
  32. Shons A. R., Simmons R. L., Kjellstrand C. M., Buselmeier T. J., Najarian J. S. Renal transplantation in patients with Australia antigenemia. Am J Surg. 1974 Nov;128(5):699–701. doi: 10.1016/s0002-9610(74)80033-4. [DOI] [PubMed] [Google Scholar]
  33. Simmons R. L., Lopez C., Balfour H., Jr, Kalis J., Rattazzi L. C., Najarian J. S. Cytomegalovirus: Clinical virological correlations in renal transplant recipients. Ann Surg. 1974 Oct;180(4):623–634. doi: 10.1097/00000658-197410000-00028. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Spencer E. S., Andersen H. K. Clinically evident, non-terminal infections with herpesviruses and the wart virus in immunosuppressed renal allograft recipients. Br Med J. 1970 Aug 1;3(5717):251–254. doi: 10.1136/bmj.3.5717.251. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Spencer E. S. Cytomegalovirus antibody in uremic patients prior to renal transplantation. Scand J Infect Dis. 1974;6(1):1–4. doi: 10.3109/inf.1974.6.issue-1.01. [DOI] [PubMed] [Google Scholar]
  36. Torisu M., Yokoyama T., Amemiya H., Kohler P. F., Schroter G., Martineau G., Penn I., Palmer W., Halgrimson C. G., Putnam C. W. Immunosuppression, liver injury, and hepatitis in renal, hepatic, and cardiac homograft recipients: with particular reference to the Australia antigen. Ann Surg. 1971 Oct;174(4):620–639. doi: 10.1097/00000658-197110000-00008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Vermillion S. E., Gregg J. A., Baggenstoss A. H., Bartholomew L. G. Jaundice associated with bacteremia. Arch Intern Med. 1969 Nov;124(5):611–618. [PubMed] [Google Scholar]
  38. Vittal S. B., Thomas W., Jr, Clowdus B. F. Acute viral hepatitis. Course and incidence of progression to chronic hepatitis. Am J Med. 1973 Dec;55(6):757–761. doi: 10.1016/0002-9343(73)90256-8. [DOI] [PubMed] [Google Scholar]
  39. Ware A. J., Luby J. P., Eigenbrodt E. H., Long D. L., Hull A. R. Spectrum of liver disease in renal transplant recipients. Gastroenterology. 1975 Apr;68(4 Pt 1):755–764. [PubMed] [Google Scholar]
  40. Whelan G., Sherlock S. Immunosuppressive activity in patients with active chronic hepatitis and primary biliary cirrhosis treated with azathioprine. Gut. 1972 Nov;13(11):907–914. doi: 10.1136/gut.13.11.907. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Zarday Z., Veith F. J., Gliedman M. L., Soberman R. Irreversible liver damage after azathioprine. JAMA. 1972 Nov 6;222(6):690–691. [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES